"HLA-DQ beta-Chains" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transmembrane proteins that form the beta subunits of the HLA-DQ antigens.
| Descriptor ID |
D059866
|
| MeSH Number(s) |
D12.776.395.550.509.400.430.750 D12.776.543.550.440.400.430.750 D23.050.301.500.400.400.430.750 D23.050.301.500.450.400.430.750 D23.050.705.552.410.400.430.750 D23.050.705.552.450.400.430.750
|
| Concept/Terms |
HLA-DQ beta-Chains- HLA-DQ beta-Chains
- HLA DQ beta Chains
- beta-Chains, HLA-DQ
- HLA Class II Histocompatibility Antigen, DQ beta Chains
|
Below are MeSH descriptors whose meaning is more general than "HLA-DQ beta-Chains".
Below are MeSH descriptors whose meaning is more specific than "HLA-DQ beta-Chains".
This graph shows the total number of publications written about "HLA-DQ beta-Chains" by people in this website by year, and whether "HLA-DQ beta-Chains" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 6 | 6 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2017 | 1 | 3 | 4 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HLA-DQ beta-Chains" by people in Profiles.
-
A Genome-Wide Association Study Identifies Two Novel Susceptible Regions for Squamous Cell Carcinoma of the Head and Neck. Cancer Res. 2020 06 15; 80(12):2451-2460.
-
HLA-B*08 Carry a Risk for Type 1 Diabetes among Cow's Milk Exposed Egyptian Infants and Unmarked Linkage Disequilibrium with DR3-DQA1*05-DQB1*02 Haplotype. Egypt J Immunol. 2019 Jan; 26(1):113-120.
-
Influences of HLA DRB1, DQA1 and DQB1 on T-cell recognition of epitopes and of larger regions of the botulinum neurotoxin molecule. Immunol Lett. 2017 10; 190:257-264.
-
Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes? J Clin Endocrinol Metab. 2017 08 01; 102(8):2873-2880.
-
Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules. J Neuroimmunol. 2017 05 15; 306:31-39.
-
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci. Sci Rep. 2017 01 23; 7:41071.
-
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). PLoS Genet. 2013; 9(1):e1003147.
-
Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans. Autoimmunity. 2011 May; 44(3):167-76.
-
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med. 2009 Jun 11; 360(24):2544-55.
-
Autoimmune pancreatitis: the emerging role of serologic biomarkers. Diabetes. 2009 Mar; 58(3):520-2.